Shanghai MicroPort EV MedTech Co. Ltd. ACompany reallocates funds from one R&D project to another, adjusting investment plans; no clear positive or negative signal on business performance.

MicroPort EP announced plans to use 217 million yuan from the Electrophysiology Interventional Medical Device R&D Project to establish a new Electrophysiology Equipment Iteration Upgrade and Market Expansion Project. The change aims to improve the efficiency of raised fund usage and adapt to market environment changes and the company's development strategy. The new project is expected to reach a usable state by July 2029. The total planned investment for the original project has been adjusted from 561 million yuan to 343 million yuan, with the reduced portion accounting for 20.32 percent of the net proceeds from the actual fundraising. As of May 31, 2026, the original project had used 242 million yuan. In the first quarter of 2026, MicroPort EP achieved revenue of 126 million yuan and a net profit attributable to the parent company of 29.08 million yuan.
Shanghai MicroPort EV MedTech Co. Ltd. ACompany reallocates funds from one R&D project to another, adjusting investment plans; no clear positive or negative signal on business performance.